September 10, 2025Open Access

The Potential Public Health Impact of the mRNA-based Respiratory Syncytial Virus Vaccine, mRNA-1345, Under Extended Vaccination Campaigns Among Older Adults in the United Kingdom: A Modelling Study

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Modeling study finds potential to prevent 310,000 hospitalisations in adults ≥60, suggesting public health improvements.

A combination of broader age eligibility and higher coverage prevents 310,000 hospitalisations over 20 years.
Vaccination strategies targeting adults aged ≥60 years could notably reduce the RSV burden in the UK.
Exploratory analyses indicate impacts may exceed current projections if vaccine efficacy patterns change.
Model validation with reported data strengthens the analysis of long-term public health impacts of vaccination.

Dronova et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark